Medizinische Universität Graz Austria/Österreich - Forschungsportal - Medical University of Graz

Logo MUG-Forschungsportal

Gewählte Publikation:

SHR Neuro Krebs Kardio Lipid

Zöhrer, E; Alisi, A; Jahnel, J; Mosca, A; Della Corte, C; Crudele, A; Fauler, G; Nobili, V.
Efficacy of docosahexaenoic acid-choline-vitamin E in paediatric NASH: a randomized controlled clinical trial.
Appl Physiol Nutr Metab. 2017; 42(9):948-954
Web of Science PubMed FullText FullText_MUG


Autor/innen der Med Uni Graz:
Fauler Günter
Jahnel Jörg
Zöhrer Evelyn

Dimensions Citations:

Plum Analytics:
Nonalcoholic steatohepatitis (NASH), a progressive form of nonalcoholic fatty liver disease, is one of the most common hepatic diseases in children. We conducted a randomized controlled clinical trial on children with biopsy-proven NASH based on a combinatorial nutritional approach compared with placebo. Participants were assigned to lifestyle modification plus placebo or lifestyle modification plus a mix containing docosahexaenoic acid, choline, and vitamin E (DHA-CHO-VE). Forty children and adolescents participated in the entire trial. The primary outcome was the improvement of liver hyperechogenicity. Secondary outcomes included alterations of alanine aminotransferase (ALT) and other metabolic parameters. Furthermore, changes of serum bile acids (BA) and plasma fibroblast growth factor 19 (FGF19) levels were evaluated as inverse biomarkers of disease severity. At the end of the study, we observed a significant decrease in severe steatosis in the treatment group (50% to 5%, p = 0.001). Furthermore, although the anthropometric and biochemical measurements in the placebo and DHA-CHO-VE groups were comparable at baseline, at the end of the study ALT and fasting glucose levels improved only in the treatment group. Finally, we found that BA levels were not influenced whereas FGF19 levels were significantly increased by DHA-CHO-VE. The results suggest that a combination of DHA, VE, and CHO could improve steatosis and reduce ALT and glucose levels in children with NASH. However, further studies are needed to assess the impact of a DHA and VE combination on repair of liver damage in paediatric NASH.
Find related publications in this database (using NLM MeSH Indexing)
Adolescent -
Biomarkers - blood
Biopsy -
Child -
Child Nutritional Physiological Phenomena -
Choline - adverse effects
Choline - therapeutic use
Combined Modality Therapy - adverse effects
Dietary Supplements - adverse effects
Disease Progression -
Docosahexaenoic Acids - adverse effects
Docosahexaenoic Acids - therapeutic use
Double-Blind Method -
Exercise -
Female -
Follow-Up Studies -
Healthy Lifestyle -
Humans -
Liver - pathology
Liver - physiopathology
Male -
Non-alcoholic Fatty Liver Disease - blood
Non-alcoholic Fatty Liver Disease - diet therapy
Non-alcoholic Fatty Liver Disease - pathology
Non-alcoholic Fatty Liver Disease - physiopathology
Severity of Illness Index -
Vitamin E - adverse effects
Vitamin E - therapeutic use

Find related publications in this database (Keywords)
bile acids
docosahexaenoic acid
nonalcoholic fatty liver disease
vitamin E
© Meduni Graz Impressum